BioRegion Real Estate | GenomeWeb

BioRegion Real Estate


Dendreon Signs Leases for New Manufacturing Facilities in Union City, Ga., and Seal Beach, Calif., as Provenge Nears Market

Dendreon used its most recent 10-Q quarterly report, filed Monday with the US Securities & Exchange Commission, to announce the creation of two manufacturing facilities at opposite ends of the US, as the drug developer gears up to bring its prostate cancer treatment Provenge to market.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In Science this week: intellectual property landscape of CRISPR genome editing, and more.

A researcher has been convicted of conspiring to steal genetically engineered rice, Reuters reports.

Harvard Medical School's George Church says a woolly mammoth-elephant hybrid is only a few years away, according to the New Scientist.

Intel is ending its sponsorship of the International Science and Engineering Fair, the New York Times reports.